Comparison of oncologic outcome of abdominoperineal resection versus sphincter saving resection for low lying rectal cancer

Purpose: The present study compares the peri/postoperative and oncological outcomes of abdominoperineal resections (APR) and sphincter saving resection (SSR) for low lying rectal cancer.Methods: Between January 2001 and December 2014, 176 patients who underwent SSR (n = 67) and APR (n = 109) for low...

Full description

Saved in:
Bibliographic Details
Published inKorean journal of clinical oncology Vol. 17; no. 2; pp. 73 - 81
Main Authors Jo, Won Il, Lim, Dae Ro, Kuk, Jung Cheol, Shin, Eung Jin
Format Journal Article
LanguageEnglish
Published Korea (South) 대한종양외과학회 01.12.2021
Korean Society of Surgical Oncology
Subjects
Online AccessGet full text
ISSN1738-8082
2288-4084
2288-4084
DOI10.14216/kjco.21012

Cover

Abstract Purpose: The present study compares the peri/postoperative and oncological outcomes of abdominoperineal resections (APR) and sphincter saving resection (SSR) for low lying rectal cancer.Methods: Between January 2001 and December 2014, 176 patients who underwent SSR (n = 67) and APR (n = 109) for low rectal cancer, without stage IV, were retrieved from a retrospective database.Results: With a median follow-up of 66.5 months. The mean total number of harvested lymph nodes was 16.7 (SSR) versus 17.1 (APR) (P = 0.801). The advanced T stage was higher in the APR group (82.6%) versus the SSR group (55.2%) (P = 0.006). The positive rate of lymph nodes after surgery was significantly higher in the APR group (45.9%) versus SSR group (25.4%) (P < 0.05). The 5-year overall survival rates for SSR and APR were 87.3% and 67.6%, respectively (P < 0.005). The 5-year disease-free survival rate (DFS) was 83.6% (SSR) versus 65.5% (APR) (P = 0.002). The recurrence rate was higher in the APR group (34.9%) versus the SSR group (14.9%) (P = 0.004). Local recurrence rate was not different between the two groups. However, distant recurrence rate was significantly higher in the APR group (26.6% vs. 11.9%, P = 0.023). In multivariate analysis, node positive (N0 vs. N1-2) was an independent prognostic factor for DFS (P < 0.005).Conclusion: Based on the present data, SSR achieved better 5-year oncological outcome than APR. The positive lymph node ratio in the N stage after surgery was higher in the APR group and this seems to have an effect on the oncological outcomes of the APR group.
AbstractList Purpose: The present study compares the peri/postoperative and oncological outcomes of abdominoperineal resections (APR) and sphincter saving resection (SSR) for low lying rectal cancer. Methods: Between January 2001 and December 2014, 176 patients who underwent SSR (n=67) and APR (n=109) for low rectal cancer, without stage IV, were retrieved from a retrospective database. Results: With a median follow-up of 66.5 months. The mean total number of harvested lymph nodes was 16.7 (SSR) versus 17.1 (APR) (P=0.801). The advanced T stage was higher in the APR group (82.6%) versus the SSR group (55.2%) (P=0.006). The positive rate of lymph nodes after surgery was significantly higher in the APR group (45.9%) versus SSR group (25.4%) (P<0.05). The 5-year overall survival rates for SSR and APR were 87.3% and 67.6%, respectively (P<0.005). The 5-year disease-free survival rate (DFS) was 83.6% (SSR) versus 65.5% (APR) (P=0.002). The recurrence rate was higher in the APR group (34.9%) versus the SSR group (14.9%) (P=0.004). Local recurrence rate was not different between the two groups. However, distant recurrence rate was significantly higher in the APR group (26.6% vs. 11.9%, P=0.023). In multivariate analysis, node positive (N0 vs. N1-2) was an independent prognostic factor for DFS (P<0.005). Conclusion: Based on the present data, SSR achieved better 5-year oncological outcome than APR. The positive lymph node ratio in the N stage after surgery was higher in the APR group and this seems to have an effect on the oncological outcomes of the APR group. KCI Citation Count: 0
The present study compares the peri/postoperative and oncological outcomes of abdominoperineal resections (APR) and sphincter saving resection (SSR) for low lying rectal cancer. Between January 2001 and December 2014, 176 patients who underwent SSR (n=67) and APR (n=109) for low rectal cancer, without stage IV, were retrieved from a retrospective database. With a median follow-up of 66.5 months. The mean total number of harvested lymph nodes was 16.7 (SSR) versus 17.1 (APR) (P=0.801). The advanced T stage was higher in the APR group (82.6%) versus the SSR group (55.2%) (P=0.006). The positive rate of lymph nodes after surgery was significantly higher in the APR group (45.9%) versus SSR group (25.4%) (P<0.05). The 5-year overall survival rates for SSR and APR were 87.3% and 67.6%, respectively (P<0.005). The 5-year disease-free survival rate (DFS) was 83.6% (SSR) versus 65.5% (APR) (P=0.002). The recurrence rate was higher in the APR group (34.9%) versus the SSR group (14.9%) (P=0.004). Local recurrence rate was not different between the two groups. However, distant recurrence rate was significantly higher in the APR group (26.6% vs. 11.9%, P=0.023). In multivariate analysis, node positive (N0 vs. N1-2) was an independent prognostic factor for DFS (P<0.005). Based on the present data, SSR achieved better 5-year oncological outcome than APR. The positive lymph node ratio in the N stage after surgery was higher in the APR group and this seems to have an effect on the oncological outcomes of the APR group.
Purpose The present study compares the peri/postoperative and oncological outcomes of abdominoperineal resections (APR) and sphincter saving resection (SSR) for low lying rectal cancer. Methods Between January 2001 and December 2014, 176 patients who underwent SSR (n=67) and APR (n=109) for low rectal cancer, without stage IV, were retrieved from a retrospective database. Results With a median follow-up of 66.5 months. The mean total number of harvested lymph nodes was 16.7 (SSR) versus 17.1 (APR) (P=0.801). The advanced T stage was higher in the APR group (82.6%) versus the SSR group (55.2%) (P=0.006). The positive rate of lymph nodes after surgery was significantly higher in the APR group (45.9%) versus SSR group (25.4%) (P<0.05). The 5-year overall survival rates for SSR and APR were 87.3% and 67.6%, respectively (P<0.005). The 5-year disease-free survival rate (DFS) was 83.6% (SSR) versus 65.5% (APR) (P=0.002). The recurrence rate was higher in the APR group (34.9%) versus the SSR group (14.9%) (P=0.004). Local recurrence rate was not different between the two groups. However, distant recurrence rate was significantly higher in the APR group (26.6% vs. 11.9%, P=0.023). In multivariate analysis, node positive (N0 vs. N1–2) was an independent prognostic factor for DFS (P<0.005). Conclusion Based on the present data, SSR achieved better 5-year oncological outcome than APR. The positive lymph node ratio in the N stage after surgery was higher in the APR group and this seems to have an effect on the oncological outcomes of the APR group.
The present study compares the peri/postoperative and oncological outcomes of abdominoperineal resections (APR) and sphincter saving resection (SSR) for low lying rectal cancer.PurposeThe present study compares the peri/postoperative and oncological outcomes of abdominoperineal resections (APR) and sphincter saving resection (SSR) for low lying rectal cancer.Between January 2001 and December 2014, 176 patients who underwent SSR (n=67) and APR (n=109) for low rectal cancer, without stage IV, were retrieved from a retrospective database.MethodsBetween January 2001 and December 2014, 176 patients who underwent SSR (n=67) and APR (n=109) for low rectal cancer, without stage IV, were retrieved from a retrospective database.With a median follow-up of 66.5 months. The mean total number of harvested lymph nodes was 16.7 (SSR) versus 17.1 (APR) (P=0.801). The advanced T stage was higher in the APR group (82.6%) versus the SSR group (55.2%) (P=0.006). The positive rate of lymph nodes after surgery was significantly higher in the APR group (45.9%) versus SSR group (25.4%) (P<0.05). The 5-year overall survival rates for SSR and APR were 87.3% and 67.6%, respectively (P<0.005). The 5-year disease-free survival rate (DFS) was 83.6% (SSR) versus 65.5% (APR) (P=0.002). The recurrence rate was higher in the APR group (34.9%) versus the SSR group (14.9%) (P=0.004). Local recurrence rate was not different between the two groups. However, distant recurrence rate was significantly higher in the APR group (26.6% vs. 11.9%, P=0.023). In multivariate analysis, node positive (N0 vs. N1-2) was an independent prognostic factor for DFS (P<0.005).ResultsWith a median follow-up of 66.5 months. The mean total number of harvested lymph nodes was 16.7 (SSR) versus 17.1 (APR) (P=0.801). The advanced T stage was higher in the APR group (82.6%) versus the SSR group (55.2%) (P=0.006). The positive rate of lymph nodes after surgery was significantly higher in the APR group (45.9%) versus SSR group (25.4%) (P<0.05). The 5-year overall survival rates for SSR and APR were 87.3% and 67.6%, respectively (P<0.005). The 5-year disease-free survival rate (DFS) was 83.6% (SSR) versus 65.5% (APR) (P=0.002). The recurrence rate was higher in the APR group (34.9%) versus the SSR group (14.9%) (P=0.004). Local recurrence rate was not different between the two groups. However, distant recurrence rate was significantly higher in the APR group (26.6% vs. 11.9%, P=0.023). In multivariate analysis, node positive (N0 vs. N1-2) was an independent prognostic factor for DFS (P<0.005).Based on the present data, SSR achieved better 5-year oncological outcome than APR. The positive lymph node ratio in the N stage after surgery was higher in the APR group and this seems to have an effect on the oncological outcomes of the APR group.ConclusionBased on the present data, SSR achieved better 5-year oncological outcome than APR. The positive lymph node ratio in the N stage after surgery was higher in the APR group and this seems to have an effect on the oncological outcomes of the APR group.
Author Dae Ro Lim
Won Il Jo
Jung Cheol Kuk
Eung Jin Shin
Author_xml – sequence: 1
  givenname: Won Il
  surname: Jo
  fullname: Jo, Won Il
– sequence: 2
  givenname: Dae Ro
  orcidid: 0000-0002-3076-1391
  surname: Lim
  fullname: Lim, Dae Ro
– sequence: 3
  givenname: Jung Cheol
  surname: Kuk
  fullname: Kuk, Jung Cheol
– sequence: 4
  givenname: Eung Jin
  surname: Shin
  fullname: Shin, Eung Jin
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36945671$$D View this record in MEDLINE/PubMed
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002801296$$DAccess content in National Research Foundation of Korea (NRF)
BookMark eNp1kt1rFDEQwBep2LP2yXfZF0GRq_naTfIilLPqQbEg9Tlks5Nr7naTa7J7UvznzX14tIJPgclvfjOZzMvixAcPRfEaowvMCK4_rpYmXBCMMHlWTAgRYsqQYCfFBHMqpgIJclqcp7RECBFJKKb1i-KU1pJVNceT4vcs9GsdXQq-DLYM3oQuLJwpwziY0MM2qJs29M6HNUTnQXdlhARmcDllAzGNqUzrO-fNALFMeuP84hFhQyy78KvsHvZxM2SB0d5AfFU8t7pLcH44z4qfX65uZ9-m1zdf57PL66mhVU2mlW2AUKFJjbkQAgE0xhKEOCGGWqxbjVkrK9CcmLYVBipLZCtbBqRpcH7zWfF-7_XRqpVxKmi3OxdBraK6_HE7V1IKRDnK7HzPtkEv1Tq6XseHXcIuEOJC6Tg404Fq8tBFI6SwDWGMaVFTwaioKgm8tRVk16e9az02PbQG_BB190T69Ma7u9zTJjfDCK9oFrw7CGK4HyENqnfJQNdpD2FMinAhOUYVlxl987jWscjfn87Ahz1gYkgpgj0iGKndKqntKqndKmUa_0MbN-jth-ZGXfefnLeHMY_ZDK3TxxLfbz5fYYw5EbWgfwAbO9to
CitedBy_id crossref_primary_10_1007_s00053_024_00834_5
crossref_primary_10_1245_s10434_024_16316_3
Cites_doi 10.1007/s00384-012-1590-8
10.1007/bf02307027
10.1007/s10434-001-0163-9
10.1155/2017/6058907
10.1055/s-2007-984865
10.1016/s0360-3016(01)02643-8
10.1097/00000658-200204000-00001
10.1002/bjs.1800810944
10.1007/s11605-010-1165-3
10.1007/s00384-017-2755-2
10.1056/nejmoa060829
10.1200/jco.2009.22.0467
10.1097/md.0000000000008249
10.1002/jso.26249
10.1136/gut.2010.211557
10.1245/s10434-014-3573-1
10.1007/s00464-013-3014-4
10.1200/jco.2007.12.7027
10.1200/jco.2007.15.3858
10.1097/sla.0b013e318195e17c
10.1007/s10350-003-0012-y
10.1136/jclinpath-2018-205592
ContentType Journal Article
Copyright Copyright © 2021 Korean Society of Surgical Oncology.
Copyright © 2021 Korean Society of Surgical Oncology 2021
Copyright_xml – notice: Copyright © 2021 Korean Society of Surgical Oncology.
– notice: Copyright © 2021 Korean Society of Surgical Oncology 2021
DBID DBRKI
TDB
AAYXX
CITATION
NPM
7X8
5PM
DOA
ACYCR
DOI 10.14216/kjco.21012
DatabaseName DBPIA - 디비피아
Nurimedia DBPIA Journals
CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
Korean Citation Index
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList
PubMed

CrossRef
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
EISSN 2288-4084
EndPage 81
ExternalDocumentID oai_kci_go_kr_ARTI_9980370
oai_doaj_org_article_b1018b898fb2444a8638438559e7df5e
PMC9942753
36945671
10_14216_kjco_21012
NODE11172868
Genre Journal Article
GroupedDBID ALMA_UNASSIGNED_HOLDINGS
DBRKI
GROUPED_DOAJ
GW5
PGMZT
RPM
TDB
AAYXX
CITATION
NPM
7X8
5PM
ACYCR
ID FETCH-LOGICAL-c3562-5fbe238a26178880eebcf200722c3f1ada14d95ea72cdd8ce5f29d9d4e2bb1923
IEDL.DBID DOA
ISSN 1738-8082
2288-4084
IngestDate Thu Dec 19 03:18:36 EST 2024
Wed Aug 27 01:28:48 EDT 2025
Thu Aug 21 18:37:29 EDT 2025
Fri Jul 11 07:30:47 EDT 2025
Thu Jan 02 22:53:06 EST 2025
Tue Jul 01 02:40:47 EDT 2025
Thu Apr 24 23:00:51 EDT 2025
Thu Feb 06 13:25:20 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords Rectal neoplasms
Surgery
Abdominoperineal resection
Language English
License Copyright © 2021 Korean Society of Surgical Oncology.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3562-5fbe238a26178880eebcf200722c3f1ada14d95ea72cdd8ce5f29d9d4e2bb1923
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
https://doi.org/10.14216/kjco.21012
ORCID 0000-0002-3076-1391
OpenAccessLink https://doaj.org/article/b1018b898fb2444a8638438559e7df5e
PMID 36945671
PQID 2789710579
PQPubID 23479
PageCount 9
ParticipantIDs nrf_kci_oai_kci_go_kr_ARTI_9980370
doaj_primary_oai_doaj_org_article_b1018b898fb2444a8638438559e7df5e
pubmedcentral_primary_oai_pubmedcentral_nih_gov_9942753
proquest_miscellaneous_2789710579
pubmed_primary_36945671
crossref_primary_10_14216_kjco_21012
crossref_citationtrail_10_14216_kjco_21012
nurimedia_primary_NODE11172868
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20211201
PublicationDateYYYYMMDD 2021-12-01
PublicationDate_xml – month: 12
  year: 2021
  text: 20211201
  day: 1
PublicationDecade 2020
PublicationPlace Korea (South)
PublicationPlace_xml – name: Korea (South)
PublicationTitle Korean journal of clinical oncology
PublicationTitleAlternate Korean J Clin Oncol
PublicationYear 2021
Publisher 대한종양외과학회
Korean Society of Surgical Oncology
Publisher_xml – name: 대한종양외과학회
– name: Korean Society of Surgical Oncology
References ref12
ref15
ref14
Rullier (ref2) 2005
ref11
ref10
ref1
Marr (ref9) 2005
ref17
ref16
Warwick (ref19) 1973
ref18
Saito (ref7) 2006
ref24
ref23
ref26
ref25
ref20
ref22
ref21
ref27
ref8
Mezhir (ref13) 2012
ref4
ref3
ref6
ref5
References_xml – ident: ref18
  doi: 10.1007/s00384-012-1590-8
– ident: ref6
  doi: 10.1007/bf02307027
– ident: ref12
  doi: 10.1007/s10434-001-0163-9
– ident: ref15
  doi: 10.1155/2017/6058907
– ident: ref14
  doi: 10.1055/s-2007-984865
– ident: ref25
  doi: 10.1016/s0360-3016(01)02643-8
– ident: ref26
  doi: 10.1097/00000658-200204000-00001
– ident: ref1
  doi: 10.1002/bjs.1800810944
– ident: ref11
  doi: 10.1007/s11605-010-1165-3
– ident: ref27
  doi: 10.1007/s00384-017-2755-2
– start-page: S13
  volume-title: Intersphincteric resection in patients with very low rectal cancer: a review of the Japanese experience
  year: 2006
  ident: ref7
– ident: ref24
  doi: 10.1056/nejmoa060829
– ident: ref4
  doi: 10.1200/jco.2009.22.0467
– ident: ref17
  doi: 10.1097/md.0000000000008249
– ident: ref16
  doi: 10.1002/jso.26249
– ident: ref20
  doi: 10.1136/gut.2010.211557
– ident: ref8
  doi: 10.1245/s10434-014-3573-1
– start-page: 706
  volume-title: Angiology
  year: 1973
  ident: ref19
– start-page: 74
  volume-title: The modern abdominoperineal excision: the next challenge after total mesorectal excision
  year: 2005
  ident: ref9
– start-page: 465
  volume-title: Sphincter-saving resection for all rectal carcinomas: the end of the 2-cm distal rule
  year: 2005
  ident: ref2
– ident: ref3
  doi: 10.1007/s00464-013-3014-4
– start-page: 274
  volume-title: Whole-mount pathologic analysis of rectal cancer following neoadjuvant therapy: implications of margin status on long-term oncologic outcome
  year: 2012
  ident: ref13
– ident: ref21
  doi: 10.1200/jco.2007.12.7027
– ident: ref23
  doi: 10.1200/jco.2007.15.3858
– ident: ref22
  doi: 10.1097/sla.0b013e318195e17c
– ident: ref10
  doi: 10.1007/s10350-003-0012-y
– ident: ref5
  doi: 10.1136/jclinpath-2018-205592
SSID ssj0002923136
ssib059951131
Score 2.1659267
Snippet Purpose: The present study compares the peri/postoperative and oncological outcomes of abdominoperineal resections (APR) and sphincter saving resection (SSR)...
The present study compares the peri/postoperative and oncological outcomes of abdominoperineal resections (APR) and sphincter saving resection (SSR) for low...
Purpose The present study compares the peri/postoperative and oncological outcomes of abdominoperineal resections (APR) and sphincter saving resection (SSR)...
SourceID nrf
doaj
pubmedcentral
proquest
pubmed
crossref
nurimedia
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 73
SubjectTerms abdominoperineal resection
Original
rectal neoplasms
surgery
일반외과학
Title Comparison of oncologic outcome of abdominoperineal resection versus sphincter saving resection for low lying rectal cancer
URI https://www.dbpia.co.kr/journal/articleDetail?nodeId=NODE11172868
https://www.ncbi.nlm.nih.gov/pubmed/36945671
https://www.proquest.com/docview/2789710579
https://pubmed.ncbi.nlm.nih.gov/PMC9942753
https://doaj.org/article/b1018b898fb2444a8638438559e7df5e
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002801296
Volume 17
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX 대한종양외과학회지, 2021, 17(2), , pp.73-81
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lj9MwELbQXuCCQLzCozJoT0hhE8eJ7SMsXS1Iu1xYaW9W_GJLu3HVhxBC4rcz42SjFq3EhUurum6qeD57vnE83xByWIRCGcl57qSDAMVZmcs2qNzW3vuqDpynDLmz8-b0gn--rC93Sn3hmbBeHrgfuCODklJGKhkMeCLeSgAMryQQYS9cqD2uvoUqdoIpQBKqaJXl8HwL12SGPCbVCywFzHAJjm9I1uOsbI7m3218x1Dqas89JRV_cDrdCj7c7bYouA9Wu42M_n2mcsdJnTwg9wd2Sd_3d_WQ3PHdI_LreKw1SGOgsbP9gkfjdgN489jYGhevZ11cpmxAuARmJaWUB4rnNrZrul5ezTpUdqbrFjchdnoA76WL-IMufvbtFgg9tQin1WNycTL9enyaDzUXclsBFcrrYDx48RaF2iE4Lrw3NuB-JmO2CmXr2pI7VftWMOuctL4OTDnluGfGIFt8Qg662PlnhAZlKqMM8AkbuHeNEQoMWTfSCIcqQhl5ezPU2g6C5FgXY6ExMEG7aLSLTnbJyOHYednrcNze7QPabOyC4tmpASClB0jpf0EqI2_A4npuZ-n3-P4t6vlKQ4jxSUN8WlSiyMhkBMT4d-dfPk7BeQgmG5mR1zco0TBl8TlM2_m4XWtMPhZYX1ll5GmPmvEKVaOA0ooyI2IPT3t3tP9NN7tKsuBKcQbB5_P_MQQvyD2Gh3fSuZ2X5GCz2vpXwL42ZpImGrye_Z5O0ubYH4nMLws
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Comparison+of+oncologic+outcome+of+abdominoperineal+resection+versus+sphincter+saving+resection+for+low+lying+rectal+cancer&rft.jtitle=Korean+journal+of+clinical+oncology&rft.au=Jo%2C+Won+Il&rft.au=Lim%2C+Dae+Ro&rft.au=Kuk%2C+Jung+Cheol&rft.au=Shin%2C+Eung+Jin&rft.date=2021-12-01&rft.pub=Korean+Society+of+Surgical+Oncology&rft.issn=1738-8082&rft.eissn=2288-4084&rft.volume=17&rft.issue=2&rft.spage=73&rft.epage=81&rft_id=info:doi/10.14216%2Fkjco.21012&rft.externalDocID=PMC9942753
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1738-8082&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1738-8082&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1738-8082&client=summon